Literature DB >> 18262304

Short-term intensive glycemic control improves vibratory sensation in type 2 diabetes.

Yoshihito Fujita1, Mitsuo Fukushima, Haruhiko Suzuki, Ataru Taniguchi, Yoshikatsu Nakai, Akira Kuroe, Koichiro Yasuda, Masaya Hosokawa, Yuichiro Yamada, Nobuya Inagaki, Yutaka Seino.   

Abstract

Strict long-term glycemic control has been reported to prevent or improve diabetic peripheral neuropathy, but the effects of short-term glycemic control have not been clarified in patients with type 2 diabetes. To investigate reversibility of impaired vibratory sensation by short-term glycemic control, we used the TM31 liminometer and C64 tuning fork methods to measure peripheral neuropathy. Thirty-one type 2 diabetes patients with poor glycemic control (HbA1c: 10.8+/-0.4%, mean+/-S.E.M., range from 7.9% to 16.2%) were administered strict glycemic control. Vibratory sensation before and after short-term glycemic control was evaluated, and the metabolic profile including plasma glucose, HbA1c, total cholesterol, HDL cholesterol, triglyceride, and free fatty acid (FFA) was measured. After 20.0+/-2.1 days of strict glycemic control, vibratory sensation improved significantly in both upper and lower extremities, assessed by TM31 liminometer and C64 tuning fork. Along with the improved glycemic control, lipid metabolism (total cholesterol, triglyceride and FFA) was significantly improved. Thus, short-term intensive glycemic control can improve vibratory sensation, metabolic changes in glucose and lipid metabolism being the factors responsible for improved of peripheral nerve function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18262304     DOI: 10.1016/j.diabres.2007.12.011

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  7 in total

1.  Dyslipidemia associated with poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation.

Authors:  Yonas Mullugeta; Rajinder Chawla; Tedla Kebede; Yesehak Worku
Journal:  Indian J Clin Biochem       Date:  2012-06-06

2.  Dyslipidemia as a contributory factor in etiopathogenesis of diabetic neuropathy.

Authors:  Fakhir S Al-Ani; Marwan S Al-Nimer; Fatima S Ali
Journal:  Indian J Endocrinol Metab       Date:  2011-04

3.  Prediction of protective sensory loss, neuropathy and foot ulceration in type 2 diabetes.

Authors:  R B Paisey; T Darby; A M George; M Waterson; P Hewson; C F Paisey; M P Thomson
Journal:  BMJ Open Diabetes Res Care       Date:  2016-05-05

4.  Relationship between Lipid Profiles and Glycemic Control Among Patients with Type 2 Diabetes in Qingdao, China.

Authors:  Shukang Wang; Xiaokang Ji; Zhentang Zhang; Fuzhong Xue
Journal:  Int J Environ Res Public Health       Date:  2020-07-23       Impact factor: 3.390

5.  Improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients.

Authors:  Lars B Dahlin; Targ Elgzyri; Magnus Löndahl; Linnéa Ekman; Eero Lindholm
Journal:  Acta Diabetol       Date:  2019-11-08       Impact factor: 4.280

6.  The association between blood glucose levels and lipids or lipid ratios in type 2 diabetes patients: A cross-sectional study.

Authors:  Liqun Wang; Ning Yan; Min Zhang; Ruiping Pan; Yuqi Dang; Yang Niu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

7.  Comparison of a multiple daily insulin injection regimen (glargine or detemir once daily plus prandial insulin aspart) and continuous subcutaneous insulin infusion (aspart) in short-term intensive insulin therapy for poorly controlled type 2 diabetes patients.

Authors:  Wen-Shan Lv; Li Li; Jun-Ping Wen; Rong-Fang Pan; Rui-Xia Sun; Jing Wang; Yu-Xin Xian; Cai-Xia Cao; Yan-Yan Gao
Journal:  Int J Endocrinol       Date:  2013-05-08       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.